Bronx
174th Street
932 E 174th St, Bronx, NY 10460
Evaluation and coordination only. Confirm an eligible clinic for the exact medicine, test, injection, insertion, removal, or infusion before treatment.
Depo-Provera CI is a medroxyprogesterone acetate contraceptive injection. The December 2025 US label includes a meningioma warning and the longstanding boxed warning about loss of bone mineral density. Discuss these risks alongside pregnancy goals and other contraceptive options.
The progestin suppresses ovulation and affects cervical mucus and the uterine lining. It prevents pregnancy but does not prevent STIs. Depo-Provera CI is the intramuscular product; a subcutaneous medroxyprogesterone product has different dose and instructions.
Review pregnancy possibility, bleeding, breast cancer, clot or stroke history, liver disease and contraindications with the clinician. Bone health matters, particularly with prolonged use. The label does not recommend use longer than two years unless other contraceptive options are considered inadequate.
The labeled CI dose is 150 mg by deep intramuscular injection every 13 weeks. Confirm when the last dose was given and the next date. If late, the clinician assesses pregnancy possibility and whether temporary backup contraception or emergency contraception is needed; do not simply repeat a dose without review.
Bring the last injection date, medicines, period and bleeding history, pregnancy possibility and previous method problems. Discuss bone-health risks, fertility plans and neurological symptoms. Ask the chosen clinic whether it actually provides the CI injection and whether an appointment and prescription are needed.
Bleeding changes and sometimes absent periods are common, but significant or persistent abnormal bleeding needs review. The current label reports meningiomas with repeated medroxyprogesterone use, primarily long term; monitor symptoms and discontinue if diagnosed. New persistent neurological symptoms need assessment. Review the bone-density warning before continuing prolonged use.
Keep reinjection dates and discuss bleeding, side effects and bone health. Return to fertility may be delayed after stopping; in label data, median time to conception among those who conceived was about ten months from the last injection, with variation. It is not a guarantee or permanent infertility. Use STI prevention separately.
Confirm the clinician and pharmacy route before starting. Visit coverage does not guarantee medication coverage, and manufacturer support or a sample does not guarantee affordable refills. Ask about authorization, testing, costs and follow-up. Confirm whether the selected clinic prescribes the product and whether the pharmacy can fill the exact dose.
The labeled CI dose is 150 mg by deep intramuscular injection every 13 weeks. Confirm when the last dose was given and the next date. If late, the clinician assesses pregnancy possibility and whether temporary backup contraception or emergency contraception is needed; do not simply repeat a dose without review.
The labeled CI dose is 150 mg by deep intramuscular injection every 13 weeks. Confirm when the last dose was given and the next date. If late, the clinician assesses pregnancy possibility and whether temporary backup contraception or emergency contraception is needed; do not simply repeat a dose without review. Keep reinjection dates and discuss bleeding, side effects and bone health. Return to fertility may be delayed after stopping; in label data, median time to conception among those who conceived was about ten months from the last injection, with variation. It is not a guarantee or permanent infertility. Use STI prevention separately.
Irregular bleeding or spotting is common with Depo-Provera, and periods may become absent with continued use. Heavy, prolonged or otherwise concerning bleeding needs review rather than assuming it is harmless. Tell the clinician if a shot is late or pregnancy is possible, since those require a separate assessment.
Yes. Depo-Provera has a boxed warning for loss of bone mineral density, which increases with duration and may not be fully reversible. Use longer than two years is not recommended unless other birth-control methods are inadequate. Discuss bone risk and alternatives with the prescriber; do not confuse this issue with the separate meningioma warning.
The December 2025 US label warns that meningioma has been reported with repeated medroxyprogesterone use, especially long-term use. Tell the clinician about a meningioma history and report new concerning neurological symptoms. If a meningioma is diagnosed, Depo-Provera should be discontinued under the treating clinician’s plan. This is separate from its boxed bone-density warning.
Return to ovulation and pregnancy can be delayed after the last Depo-Provera shot. In label data, the median time to conception among those who conceived was 10 months after the last injection. That is not a guarantee for an individual. Discuss your pregnancy timeline when selecting or stopping contraception.
No. Depo-Provera, IUDs and Nexplanon prevent pregnancy but do not protect against STIs. Discuss condoms, exposure-specific testing and other prevention with the clinician.
Confirm the exact service at the selected clinic before booking. Evaluation, prescribing, testing, training and administration are separate capabilities. Confirm the clinician and pharmacy route before starting. Visit coverage does not guarantee medication coverage, and manufacturer support or a sample does not guarantee affordable refills. Ask about authorization, testing, costs and follow-up. Confirm whether the selected clinic prescribes the product and whether the pharmacy can fill the exact dose.
Before treatment starts, confirm the diagnosis, the intended benefit, the exact treatment and who will coordinate ongoing care. The labeled CI dose is 150 mg by deep intramuscular injection every 13 weeks. Confirm when the last dose was given and the next date. If late, the clinician assesses pregnancy possibility and whether temporary backup contraception or emergency contraception is needed; do not simply repeat a dose without review.
Prepare the relevant dated records, current medicine list and your main questions, and confirm any treatment-specific instructions before attending. Bring the last injection date, medicines, period and bleeding history, pregnancy possibility and previous method problems. Discuss bone-health risks, fertility plans and neurological symptoms. Ask the chosen clinic whether it actually provides the CI injection and whether an appointment and prescription are needed.
Agree on the next review, how response and safety will be checked, and who to contact for symptoms, missed treatment or a refill problem. Keep reinjection dates and discuss bleeding, side effects and bone health. Return to fertility may be delayed after stopping; in label data, median time to conception among those who conceived was about ten months from the last injection, with variation. It is not a guarantee or permanent infertility. Use STI prevention separately.
Bronx
932 E 174th St, Bronx, NY 10460
Evaluation and coordination only. Confirm an eligible clinic for the exact medicine, test, injection, insertion, removal, or infusion before treatment.
Queens
37-15 23rd Ave, Astoria, NY 11105
Evaluation and coordination only. Confirm an eligible clinic for the exact medicine, test, injection, insertion, removal, or infusion before treatment.
Bronx
2063A Bartow Ave, Bronx, NY 10475
Evaluation and coordination only. Confirm an eligible clinic for the exact medicine, test, injection, insertion, removal, or infusion before treatment.
Brooklyn
341 Eastern Pkwy, Brooklyn, NY 11216
Evaluation and coordination only. Confirm an eligible clinic for the exact medicine, test, injection, insertion, removal, or infusion before treatment.
Long Island
232 W Old Country Rd, Hicksville, NY 11801
Evaluation and coordination only. Confirm an eligible clinic for the exact medicine, test, injection, insertion, removal, or infusion before treatment.
Queens
80-10 Northern Blvd, Jackson Heights, NY 11372
Evaluation and coordination only. Confirm an eligible clinic for the exact medicine, test, injection, insertion, removal, or infusion before treatment.
Queens
90-18 Sutphin Blvd, Jamaica, NY 11435
Evaluation and coordination only. Confirm an eligible clinic for the exact medicine, test, injection, insertion, removal, or infusion before treatment.
Queens
30-07 36th Ave, Astoria, NY 11106
Evaluation and coordination only. Confirm an eligible clinic for the exact medicine, test, injection, insertion, removal, or infusion before treatment.
Long Island
135 Mineola Blvd, Mineola, NY 11501
Evaluation and coordination only. Confirm an eligible clinic for the exact medicine, test, injection, insertion, removal, or infusion before treatment.
Manhattan
259 1st Ave, New York, NY 10003
Evaluation and coordination only. Confirm an eligible clinic for the exact medicine, test, injection, insertion, removal, or infusion before treatment.
Brooklyn
308 Graham Ave, Brooklyn, NY 11211
Evaluation and coordination only. Confirm an eligible clinic for the exact medicine, test, injection, insertion, removal, or infusion before treatment.
Compare longer-acting device options and procedure requirements.
Review contraception with preventive and gynecologic needs.
Keep cervical screening decisions separate from birth control.
Add confidential testing when it fits the visit.
Arrange an evaluation to discuss suitable care, preparation and follow-up with a clinician.
Arrange an evaluation to discuss suitable care, preparation and follow-up with a clinician.
Content was updated August 1, 2026 using the sources cited above. Medical guidance, prescribing information, medication availability, and insurance rules can change. A licensed clinician must confirm current information and determine each patient's eligibility, testing, treatment, administration setting, and follow-up. Call 911 for a medical emergency. Contact Nao Medical with a question or correction.